Author

Gong Chen

Jinan UniversityORCID 0000-0002-5067-9889Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Organism:mouse· 1

Frequent Co-Authors

Aathmaja Anandhi RangarajaniD· 1 shared Andrew CamilliiD· 1 shared Ashley Luo· 1 shared Christopher M. WatersiD· 1 shared Houlin Li· 1 shared Jacob BourgeoisiD· 1 shared Jianhua LiniD· 1 shared Kang LuiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Aathmaja Anandhi RangarajanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Phage Ejectosome Protein Moonlights to Inhibit CBASS Anti-Viral Defense System

Gong Chen, Ashley Luo, Jacob Bourgeois, Aathmaja Anandhi Rangarajan, Andrew Camilli, Christopher M. Waters, Wai‐Leung Ng

The paper identifies Gp15, a phage DNA ejection protein that inhibits the CBASS effector CapV to evade bacterial antiviral defense.

bioRxiv · Jul 23, 2025 · PreprintMicrobiology

Antibodies against the capsid induced after intracranial AAV administration limits second administration in a dose dependent manner

Y.-G. Xu, Xiaoni Bai, Jianhua Lin, Kang Lu, Shihan Weng, Yi‐Ying Wu, Shanggong Liu, Houlin Li, Zheng Wu, Gong Chen, Wen Li

This study shows that high-dose AAV injection in mice induces neutralizing antibodies that limit subsequent AAV infections, with B cells playing a key role.

Molecular Therapy — Methods & Clinical Development · Jan 25, 2025Peer-reviewedImmunology